EASY LIFE
Device Facts
| Record ID | K023521 |
|---|---|
| Device Name | EASY LIFE |
| Applicant | Berkline Corp. |
| Product Code | INO · Physical Medicine |
| Decision Date | Nov 19, 2002 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 890.3110 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Indications for Use
The intended use of the Berkline Model Easy Lift Series Lift Out Chair to assist persons who have difficulty rising from a seated position to a standing position.
Device Story
Electrically powered, motor-driven lift chair; assists users in transitioning from seated to standing position. Components include welded steel frame, upholstered chair assembly, and motorized lift actuator. Operated via handheld pendant control. Used in home or extended care environments by elderly or physically challenged individuals. Provides mechanical assistance to improve mobility and independence.
Clinical Evidence
Bench testing only. Device meets UL 1647 (Motor-Operated Massage and Exercise Machines) and UL 73 (Motor Operated Appliances). Upholstery meets California TB 117 flammability standards and UFAC Class I fabric classification.
Technological Characteristics
Electrically powered, motor-driven positioning chair. Construction: welded steel frame, upholstered assembly. Actuation: motorized lift actuator with handheld pendant control. Standards: UL 1647, UL 73, California TB 117, UFAC Class I. No software or electronic algorithms.
Indications for Use
Indicated for elderly or physically challenged individuals who have difficulty rising from a seated position to a standing position.
Regulatory Classification
Identification
An electric positioning chair is a device with a motorized positioning control that is intended for medical purposes and that can be adjusted to various positions. The device is used to provide stability for patients with athetosis (involuntary spasms) and to alter postural positions.
Special Controls
(1) Appropriate analysis and non-clinical testing must demonstrate that the safety controls are adequate to ensure safe use of the device and prevent user falls from the device in the event of a device failure; (2) Appropriate analysis and non-clinical testing must demonstrate the ability of the device to withstand the rated user weight load with an appropriate factor of safety; (3) Appropriate analysis and non-clinical testing must demonstrate the longevity of the device to withstand external forces applied to the device and provide the user with an expected service life of the device; (4) Appropriate analysis and non-clinical testing must demonstrate proper environments of use and storage of the device to maximize the longevity of the device; (5) Appropriate analysis and non-clinical testing (such as that outlined in the currently FDA-recognized editions of ANSI/AAMI/ES60601-1, “Medical Electrical Equipment—Part 1: General Requirements for Basic Safety and Essential Performance,” and ANSI/AAMI/IEC 60601-1-2, “Medical Electrical Equipment—Part 1-2: General Requirements for Basic Safety and Essential Performance—Collateral Standard: Electromagnetic Disturbances—Requirements and Tests”) must validate electromagnetic compatibility and electrical safety; (6) Appropriate analysis and non-clinical testing (such as that outlined in the currently FDA-recognized editions of ANSI/AAMI/ISO 10993-1, “Biological Evaluation of Medical Devices—Part 1: Evaluation and Testing Within a Risk Management Process,” ANSI/AAMI/ISO 10993-5, “Biological Evaluation of Medical Devices—Part 5: Tests for In Vitro Cytotoxicity,” and ANSI/AAMI/ISO 10993-10, “Biological Evaluation of Medical Devices—Part 10: Tests for Irritation and Skin Sensitization”) must validate that the skin-contacting components of the device are biocompatible; (7) Appropriate analysis and non-clinical testing (such as that outlined in the currently FDA-recognized editions of IEC 62304, “Medical Device Software—Software Life Cycle Processes”) must validate the software life cycle and that all processes, activities, and tasks are implemented and documented; (8) Appropriate analysis and non-clinical testing must validate that the device components are found to be non-flammable; (9) Appropriate analysis and non-clinical testing must validate that the battery in the device (if applicable) performs as intended over the anticipated service life of the device; and (10) Adequate patient labeling is provided to the user to document proper use and maintenance of the device to ensure safe use of the device by the patient in the intended use environment.